Omicron the New COVID-19 Variant, a Review

Authors

  • Mustafa Abdallh Department of Chemistry, College of Science, Al-Nahrain University, Baghdad-Iraq
  • Amani A. Husain 2Polymer Research Unit, College of Science, Al-Mustansiriyah University, Baghdad-Iraq 3College of Science, Al-Nahrain University, Baghdad-Iraq
  • Israa Salman College of Science, Al-Nahrain University, Baghdad-Iraq
  • Rasha Raheem Alkarkh Health Directorate, Baghdad, Iraq Department of Chemistry, Baghdad-Iraq
  • Nany Hairunisa Department of Occupational Medicine, Faculty of Medicine, Trisakti University, Jakarta-Indonesia
  • Husnun Amalia Department of Occupational Medicine, Faculty of Medicine, Trisakti University, Jakarta-Indonesia
  • Raghda Alsayed Department of Chemistry, College of Science, Al-Nahrain University, Baghdad-Iraq
  • Randa Mohammed Department of Chemistry, College of Science, Al-Nahrain University, Baghdad-Iraq
  • Emad Yousif Department of Chemistry, College of Science, Al-Nahrain University, Baghdad-Iraq

Keywords:

Omicron, COVID-19, Pandemic, Vaccine, B.1.1.529

Abstract

SARS-CoV-2 virus (COVID-19), the cause of coronavirus disease, has several variations. Some are thought to be particularly important or have been said to be so, because of their potential for greater transmissibility, Virus pathogenicity has grown, or vaccinations against them have become less effective. These mutations have a role in the COVID-19 pandemic's persistence.

The B.1.1.529-Omicron variant, found in many coronavirus cases reported in South Africa discovered late 2021, having a surprisingly great number of mutations which raise a concern toward the spreadablity of this variant and severity of illness in comparison to other corona virus variants as well as the effectivity of the available vaccinations. This review summarizes of the most recent information and the answers to most of the world's questions about Omicron.

Downloads

Published

2022-03-28

Issue

Vol. 25 No. 1 (2022): March

Section

Articles

How to Cite

(1)
Omicron the New COVID-19 Variant, a Review. ANJS 2022, 25 (1), 64-67.

Most read articles by the same author(s)

<< < 1 2 3 4 > >>